4/A

AMENDMENT TO FORM 4

Company: Oncotelic Therapeutics, Inc.
Filed: September 15, 2010
Period of Report: July 1, 2010
Accession Number: 0001181431-10-046858

View Document ↗ View on SEC.gov ↗